Knivsta, Sweden

Andrew Mott

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
7 patents (USPTO):

Title: Innovations by Andrew Mott in the Field of Obesity Treatment

Introduction

Andrew Mott is a notable inventor based in Knivsta, Sweden, recognized for his contributions to medical research and innovation. He holds a total of seven patents, focusing primarily on compounds that address obesity and related medical conditions. His work has the potential to significantly impact the treatment of obesity and type II diabetes.

Latest Patents

Among his latest patents, Mott has developed aryl sulfonamide compounds for treating obesity. This invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds, which are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and disorders of the central nervous system. Another significant patent involves substituted naphthalene sulfonamides, which are also aimed at treating obesity and related medical conditions.

Career Highlights

Andrew Mott is currently associated with Biovitrum AB, a company that focuses on biopharmaceuticals. His work at Biovitrum has allowed him to explore innovative solutions in the medical field, particularly in the area of obesity treatment. His patents reflect a commitment to advancing healthcare through scientific research and innovation.

Collaborations

Mott has collaborated with notable colleagues such as Ulf J Bremberg and Patrizia Caldirola. These collaborations have likely contributed to the development of his innovative patents and have fostered a productive research environment.

Conclusion

In summary, Andrew Mott's contributions to the field of obesity treatment through his innovative patents highlight his role as a significant inventor in medical research. His work continues to pave the way for advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…